Tutorials
Regeneron Pharmaceuticals Inc logo

Regeneron Pharmaceuticals Inc

$ 613.61 -1.35 (-0.22%) 10:08 PM EST
On watch
P/E:
12.25
P/B:
3.25
Market Cap:
$ 66.89B
Enterprise V:
$ 62.02B
Volume:
566.48K
Avg Vol (2M):
654.10K
Also Trade In:
Volume:
566.48K
Market Cap $:
66.89B
PE Ratio:
12.25
Avg Vol (2-Month):
654.10K
Enterprise Value $:
62.02B
PB Ratio:
3.25
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Regeneron Pharmaceuticals Inc
NAICS : 325412 SIC : 2834
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Description
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.

Financials (Next Earnings Date:2022-11-04 Est.)

REGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:REGN

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 14,226.8
EPS (TTM) ($) 50.1
Beta 0.12
Volatility % 29
14-Day RSI 58.73
14-Day ATR ($) 18.393922
20-Day SMA ($) 594.9665
12-1 Month Momentum % -0.98
52-Week Range ($) 538.01 - 747.4214
Shares Outstanding (Mil) 109.01

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Regeneron Pharmaceuticals Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More